Verification dossier
Licenses, certificates & published research
Every claim we make about Ionspec eyewear traces back to a document issued by someone other than us. Here they all are — trademark registration, materials and safety testing, far-infrared laboratory reports from Malaysia and Korea, and the peer-reviewed paper published on the design. Tap any document to read it at full size.
Contents
| Document | Territory |
|---|---|
| Medical Device Registration | MY |
| Establishment Licence | MY |
| Good Distribution Practice (GDPMD) | MY |
| Medical Device Notification (CMDN) | PH |
| Ionspec Trademark | PH |
| Trademark registration | JP |
| Trademark registration | CN |
| Utility model patent | CN |
| Design patent | CN |
| Invention patent | CN |
| Blue light & UV transmission test | CN |
| RoHS restricted substances report | EU |
| Frame material analysis | CN |
| Effectiveness test report | MY |
| Certificate of Conformity | INTL |
| RoHS Compliance Certificate | EU |
| Chemical Laboratory Report | MY |
| Calorimetry & FTIR Test Report | MY |
| Anion Emission Test (KFIM-003) | KR |
| Far Infrared Test Report | KR |
| Far Infrared Test Report II | KR |
| Certificate of Effectiveness | INTL |
| Published study & DOI record | DOI |
Ownership
The mark
Ionspec is a registered trademark. If it doesn't carry the mark, it isn't ours — which matters, because counterfeits of ion eyewear circulate widely.
Materials & safety
What the frames are made of
These certify composition and restricted-substance limits — the checks that establish the product is safe to wear against skin all day.
Laboratory testing
Measuring what the material emits
Far-infrared output and negative-ion release are physical properties, and both can be measured. These reports record emissivity, emission spectra and anion counts under laboratory conditions — they describe what the material emits, not what it does to a wearer.
Published research
The paper
A study on the Ionspec design was published in 2023 with a registered DOI. Below is the record and a plain summary of what the authors did and reported.
Potential of Photonic Effects of Ionspec Medical Design in Controlling Symptomatic Characteristics in People with Headache, High Blood Pressure, and Intraocular Pressure
What the design is
Ionspec frames are made with tourmaline processed into a superfine powder. Tourmaline occurs naturally with a permanent electrostatic charge and emits in the far-infrared band. The paper describes the design as a nanobiophotonic construction — combining that far-infrared emission with negative ion release in a wearable frame.
How the study was run
Ten participants — five men and five women — who reported ongoing eye discomfort and headaches wore Ionspec frames for six months. Outcomes were gathered through questionnaires and interviews, so the results are participant-reported rather than instrument-measured across the board. A non-wearing control subject was followed alongside them.
What the authors reported
- Most participants described relief from computer vision syndrome symptoms — eye strain, bifrontal pain and headaches — over the wear period.
- Several reported better sleep quality and less end-of-day eye fatigue.
- The authors recorded reductions in intraocular pressure among participants with elevated readings, and improvements in measured visual acuity in that subgroup.
- Some participants showed lower blood pressure readings during the study period.
- The control subject, who did not wear the frames, reported no improvement over the same period.
- The paper's own conclusion is that the design shows promise as a non-invasive complementary approach, and that longer studies with larger groups are needed.
Intellectual property
Marks and patents
Trademark registrations held in Japan and China, and patents granted in China to the Ionspec inventor, Soon Lee Fong.
All four patents are held by Soon Lee Fong. Chinese design and utility model patents are granted after a formality review rather than a full substantive examination, and both run for ten years from their filing date — the design patent for the spectacles was filed in 2014 and the utility model in 2012, so those terms have now run. The invention patent covers a wellness additive for neck and shoulder comfort rather than the spectacles themselves. The trademark registrations above remain current. We list all of this accurately so you can see exactly what is protected, and for how long.
Independent testing
Optical and material reports
Third-party laboratory work on the lens and frame — light transmission, restricted substances, and material composition.
The optical report measures how much light at each wavelength passes through the lens; the RoHS report confirms restricted substances were not detected above limits. Both describe properties of the product. The 2012–13 effectiveness report from Taipei TCM Medical Centre is a small observational study by its named researchers — it reports their observations and is not a controlled clinical trial.
Regulatory status
Where our registrations stand
Medical device registrations run on fixed terms and have to be renewed. We publish the current status of ours openly, including where a renewal is still in progress.
Philippines — Certificate of Medical Device Notification
Food and Drug Administration, Department of Health- Product
- MGI IonSpec Nano Wellness Spectacle
- CMDN number
- CDRRHR-CMDN-2020-720119
- Classification
- Class A
- Issued
- 07 December 2020
- Term ended
- 07 December 2025
- Status
- Renewal in process
Malaysia — Medical Device Registration
Medical Device Authority · Act 737, Section 5(1)- Registration number
- GA10865523-148219
- Registered holder
- EPORT SDN BHD, Kuala Lumpur
- Legal basis
- Medical Device Act 2012 (Act 737)
- Valid
- 20 September 2023 – 19 September 2028
- Status
- Current
Malaysia — Good Distribution Practice for Medical Devices
MEDCERT Malaysia · Conformity Assessment Body, MDA- Certified entity
- EPORT SDN BHD, Kuala Lumpur
- Scope
- Authorised representative, importer and distributor of medical devices
- Certificate number
- 20345EN44020220429
- Term ended
- 15 April 2025
- Status
- Renewal in process
Malaysia — Establishment Licence
Medical Device Authority · Act 737, Section 15(1)- Licence number
- MDA-3521-WDP122
- Licensee
- EPORT SDN BHD — authorised representative, distributor and importer
- Person responsible
- Soon Lee Fong
- Term ended
- 16 May 2025
- Status
- Renewal in process
A Philippine CMDN is a notification that a Class A device may be marketed here; it is not a finding that the product treats any condition. The Malaysian certificate above covers the distributor's handling and distribution systems, not the device itself. Both are on fixed terms and both are currently being renewed. While a renewal is pending we describe Ionspec only as everyday eyewear designed for comfort and eye protection, and we make no treatment claims. If you would like to see either certificate in full, or check the current status, ask us and we will send you the file.
How to read this evidence
We publish these documents in full so you can judge them yourself, and we'd rather be straight with you about what each one covers.
The laboratory reports from SIRIM and the Korea Far Infrared Association measure physical properties of the material — how much far-infrared energy it emits, and how many negative ions it releases. They are strong evidence that the emission is real and measurable. They are not clinical trials and do not test health outcomes. The anion certificate records 410 ion/cc from an 11 g sample under controlled laboratory conditions, against 104 ion/cc in the surrounding air; it was issued for quality-control purposes, and the figure describes the material tested rather than what a wearer experiences in daily use.
The published paper reports outcomes from ten participants over six months, based largely on their own accounts. That is a small, unblinded study. Findings from a study that size point to something worth investigating further — they are not proof of a treatment effect, and the authors say as much themselves.
Ionspec Eyewear is not a substitute for an eye examination, prescription correction, or medical care. It is not sold as a treatment for glaucoma, hypertension, or any other condition, and we do not claim it diagnoses, treats, or cures disease. If you have persistent headaches, vision changes, or raised eye pressure, please see an optometrist or physician.
Questions about any document here?
We'll send you the original file, or connect you with a distributor near you.